Dr Angela Pizzolla
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
42 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Antigen specificity, not tissue compartment, determines clonal sharing among respiratory tract CD8 resident memory T cells
DOI: 10.1111/imcb.700982025
Journal article
Evaluating CD103 intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal Cancer
DOI: 10.1016/j.oraloncology.2025.1077922025
Thesis / Dissertation
Understanding treatment outcomes to immune-checkpoint inhibitors in patients with non-melanomatous skin cancers
2025
Research grants (ARC, NHMRC, MRFF)
Defining Immunotherapy Response and Resistance Mechanisms in Cutaneous Squamous Cell Carcinoma.
2024
Journal article
Tissue resident memory (TRM) T cells and dendritic cells form an in situ archetype for improved response to immune checkpoint therapy in metastatic melanoma
DOI: 10.1158/2326-6074.TUMIMM24-A0062024
Journal article
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint Inhibitors
DOI: 10.3390/cancers160814522017
Research Grant
CASS 2017 Travel Award
RECENT SCHOLARLY WORKS
2024
Conference Proceedings
Immunotherapy in advanced cutaneous non-melanomatous spindle cell neoplasms
DOI: 10.1158/1538-7445.AM2024-50942024
Journal article
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancer
DOI: 10.1016/j.oraloncology.2024.1066872023
Journal article
Spatial analysis with SPIAT and spaSim to characterize and simulate tissue microenvironments
DOI: 10.1038/s41467-023-37822-02022
Conference Proceedings
REAL WORLD EXPERIENCE OF IMMUNOTHERAPY IN AN ELDERLY TRIAL-INELIGIBLE COHORT OF PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
DOI: 10.1136/jitc-2022-SITC2022.12592022
Journal article
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment
DOI: 10.1136/JITC-2022-0045742022
Journal article
Characterization of the treatment-naive immune microenvironment in melanoma with BRAF mutation
DOI: 10.1136/jitc-2021-004095